129 related articles for article (PubMed ID: 38237861)
21. Thrombocytopathy leading to impaired in vivo haemostasis and thrombosis in platelet type von Willebrand disease.
Kaur H; Corscadden K; Ware J; Othman M
Thromb Haemost; 2017 Feb; 117(3):543-555. PubMed ID: 28004055
[TBL] [Abstract][Full Text] [Related]
22. Translational insights into mechanisms underlying residual venous obstruction and the role of factor XI, P-selectin and GPVI in recurrent venous thromboembolism.
Iding AFJ; Kremers BMM; Nagy M; Pallares Robles A; Ten Cate H; Spronk HMH; Ten Cate-Hoek AJ
Thromb Res; 2023 Jan; 221():58-64. PubMed ID: 36473362
[TBL] [Abstract][Full Text] [Related]
23. Ex vivo properties of plasma clot formation and lysis in patients with cancer at risk for venous thromboembolism, arterial thrombosis, and death.
Posch F; Hofer S; Thaler J; Hell L; Königsbrügge O; Grilz E; Mauracher LM; Gebhart J; Marosi C; Jilma B; Pabinger I; Ay C
Transl Res; 2020 Jan; 215():41-56. PubMed ID: 31525325
[TBL] [Abstract][Full Text] [Related]
24. Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential.
Yamamoto J; Inoue N; Otsui K; Ishii H; Gorog DA
Thromb Res; 2014 May; 133(5):919-26. PubMed ID: 24613697
[TBL] [Abstract][Full Text] [Related]
25. Collagen/endogenous thrombin-induced platelet aggregation in cord versus adult whole blood.
Cvirn G; Kutschera J; Wagner T; Ferstl U; Vrecko K; Hallstrom S; Juergens G; Koestenberger M
Neonatology; 2009; 95(2):187-92. PubMed ID: 18797172
[TBL] [Abstract][Full Text] [Related]
26. Effects of platelets activated by different agonists on fibrin formation and thrombin generation.
Muravlev IA; Dobrovolsky AB; Antonova OA; Khaspekova SG; Mazurov AV
Platelets; 2023 Dec; 34(1):2139365. PubMed ID: 36325627
[TBL] [Abstract][Full Text] [Related]
27. Coagulation Signaling through PAR1 as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma.
Kothari A; Flick MJ
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066284
[TBL] [Abstract][Full Text] [Related]
28. Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study.
Fotiou D; Sergentanis TN; Papageorgiou L; Stamatelopoulos K; Gavriatopoulou M; Kastritis E; Psaltopoulou T; Salta S; Van Dreden P; Sangare R; Larsen AK; Terpos E; Elalamy I; Dimopoulos MA; Gerotziafas GT
Blood Cancer J; 2018 Nov; 8(11):102. PubMed ID: 30405097
[TBL] [Abstract][Full Text] [Related]
29. Serum platelet factor 4 is an independent predictor of survival and venous thromboembolism in patients with pancreatic adenocarcinoma.
Poruk KE; Firpo MA; Huerter LM; Scaife CL; Emerson LL; Boucher KM; Jones KA; Mulvihill SJ
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2605-10. PubMed ID: 20729288
[TBL] [Abstract][Full Text] [Related]
30. Crucial roles of red blood cells and platelets in whole blood thrombin generation.
Sun S; Campello E; Zou J; Konings J; Huskens D; Wan J; Fernández DI; Reutelingsperger CPM; Ten Cate H; Toffanin S; Bulato C; de Groot PG; de Laat B; Simioni P; Heemskerk JWM; Roest M
Blood Adv; 2023 Nov; 7(21):6717-6731. PubMed ID: 37648671
[TBL] [Abstract][Full Text] [Related]
31. Thrombin-PAR1 signaling in pancreatic cancer promotes an immunosuppressive microenvironment.
Schweickert PG; Yang Y; White EE; Cresswell GM; Elzey BD; Ratliff TL; Arumugam P; Antoniak S; Mackman N; Flick MJ; Konieczny SF
J Thromb Haemost; 2021 Jan; 19(1):161-172. PubMed ID: 33064371
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic cancer and thromboembolic disease.
Khorana AA; Fine RL
Lancet Oncol; 2004 Nov; 5(11):655-63. PubMed ID: 15522652
[TBL] [Abstract][Full Text] [Related]
33. Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial.
Orsi FA; Biedermann JS; Kruip MJHA; van der Meer FJ; Rosendaal FR; van Hylckama Vlieg A; Bos MHA; Leebeek FWG; Cannegieter SC; Lijfering WM
J Thromb Haemost; 2019 Feb; 17(2):319-328. PubMed ID: 30565854
[TBL] [Abstract][Full Text] [Related]
34. Onset of Thrombin Generation Occurs More Rapidly in Pediatric Patients With Celiac Disease.
Deutschmann A; Schlagenhauf A; Leschnik B; Hoffmann KM; Hauer A; Muntean W
J Pediatr Gastroenterol Nutr; 2015 Aug; 61(2):230-3. PubMed ID: 25793906
[TBL] [Abstract][Full Text] [Related]
35. COVID-19 patients exhibit reduced procoagulant platelet responses.
Denorme F; Manne BK; Portier I; Petrey AC; Middleton EA; Kile BT; Rondina MT; Campbell RA
J Thromb Haemost; 2020 Nov; 18(11):3067-3073. PubMed ID: 32945081
[TBL] [Abstract][Full Text] [Related]
36. Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors.
Tripodi A; Ammollo CT; Semeraro F; Colucci M; Malchiodi E; Verrua E; Ferrante E; Arnaldi G; Trementino L; Padovan L; Chantarangkul V; Peyvandi F; Mantovani G
Endocrine; 2017 May; 56(2):298-307. PubMed ID: 27448294
[TBL] [Abstract][Full Text] [Related]
37. Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice.
Geddings JE; Hisada Y; Boulaftali Y; Getz TM; Whelihan M; Fuentes R; Dee R; Cooley BC; Key NS; Wolberg AS; Bergmeier W; Mackman N
J Thromb Haemost; 2016 Jan; 14(1):153-66. PubMed ID: 26516108
[TBL] [Abstract][Full Text] [Related]
38. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS
J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood.
French SL; Arthur JF; Lee H; Nesbitt WS; Andrews RK; Gardiner EE; Hamilton JR
J Thromb Haemost; 2016 Aug; 14(8):1642-54. PubMed ID: 26878340
[TBL] [Abstract][Full Text] [Related]
40. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
Moik F; Prager G; Thaler J; Posch F; Wiedemann S; Schramm T; Englisch C; Mackman N; Pabinger I; Ay C
Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2837-2847. PubMed ID: 34470475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
